David J. Arthur
Board Member
Decoy Therapeutics Inc. (DCOY)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About David J. Arthur
David J. Arthur is recorded as Board Member at Decoy Therapeutics Inc. (DCOY). Decoy Therapeutics Inc. reported in an 8-K filed August 18, 2025 that David J. Arthur resigned as Chief Executive Officer, effective August 17, 2025. The proxy statement of Decoy Therapeutics Inc. reports total compensation of $941,023 for David J. Arthur in fiscal 2022, including a base salary of $500,000. Disclosed compensation is on record for 2 fiscal years.
“The Acting CEO Appointment was made in connection with the resignation of David J. Arthur as Chief Executive Officer of the Company on August 17, 2025.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Start not stated–2025-08-17
-
Start not stated–2025-08-17
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Decoy Therapeutics Inc.
Other people whose current roles at this company are on record from its filings.
- Frederick E. Pierce CEO, Board Member
- Mark J. Rosenblum CFO
- Arnold C. Hanish Board Member
- Jonathan Lieber Board Member
- Patricia Gauthier Board Member
- Paul Lammers Board Member
- Tess Burleson Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Decoy Therapeutics Inc. (DCOY) | President and Chief Executive Officer Mark J. Rosenblum Executive Vice President, Finance and Chief Financial Officer | $500,000 | $941,023 |
| 2021 | Decoy Therapeutics Inc. (DCOY) | President and Chief Executive Officer Mark J. Rosenblum Executive Vice President, Finance and Chief Financial Officer | $378,750 | $676,755 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.